Akso Health Group
9 hedge funds and large institutions have $1.48M invested in Akso Health Group in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
125% more funds holding
Funds holding: 4 → 9 (+5)
79% more capital invested
Capital invested by funds: $829K → $1.48M (+$655K)
0.61% more ownership
Funds ownership: 0.71% → 1.32% (+0.61%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.13M |
| 2 |
Two Sigma Investments
New York
|
+$719K |
| 3 |
DTL
Dynamic Technology Lab
Singapore
|
+$52.7K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$38.5K |
| 5 |
Morgan Stanley
New York
|
+$32.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$34K |
AHG Hedge Fund Activity: Q4 2021 in Review
9 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q4 2021, worth a combined $1.48M — up 79% from $829K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new AHG positions and 1 closed out — a net gain of 5 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $1.13M. The largest seller was Citadel Advisors, exiting entirely with an estimated $34K sold.
- 9 institutional investors held Akso Health Group (AHG) as of Q4 2021, up from 4 in Q3 2021.
- Funds reported $1.48M of Akso Health Group stock for Q4 2021, up 79% quarter-over-quarter.
- 6 funds opened new Akso Health Group positions in Q4 2021 and 1 closed out, a net change of +5 holders.
- The largest Akso Health Group buyer in Q4 2021 was Renaissance Technologies, an estimated $1.13M added.
- The largest Akso Health Group seller in Q4 2021 was Citadel Advisors, an estimated $34K sold.
Based on aggregated 13F filings for Q4 2021.